Literature DB >> 1440719

Experimental evidence of ischemic thresholds and functional recovery.

W D Heiss1.   

Abstract

BACKGROUND: Impaired blood flow below certain critical levels and an insufficient supply of energy-rich substrates cause failure of neuronal function, triggering biochemical disturbances that eventually lead to ischemic cell damage. SUMMARY OF REVIEW: This article reviews experimental studies that attempted to define those ischemic thresholds using functional and histological markers and, more recently, chemical markers of ischemic damage.
CONCLUSIONS: The duration of ischemia causing irreversible cell damage still is ill defined. Reestablishment of sufficient perfusion must be induced very early after an ischemic attack to ameliorate the potentially harmful biochemical sequelae of transient ischemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1440719     DOI: 10.1161/01.str.23.11.1668

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  28 in total

1.  Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside.

Authors:  Mingming Ning; David A Sarracino; Ferdinando S Buonanno; Bryan Krastins; Sherry Chou; David McMullin; Xiaoying Wang; Mary Lopez; Eng H Lo
Journal:  Transl Stroke Res       Date:  2010-12-01       Impact factor: 6.829

2.  Defining the ischemic penumbra using magnetic resonance oxygen metabolic index.

Authors:  Hongyu An; Andria L Ford; Yasheng Chen; Hongtu Zhu; Rosana Ponisio; Gyanendra Kumar; Amirali Modir Shanechi; Naim Khoury; Katie D Vo; Jennifer Williams; Colin P Derdeyn; Michael N Diringer; Peter Panagos; William J Powers; Jin-Moo Lee; Weili Lin
Journal:  Stroke       Date:  2015-02-26       Impact factor: 7.914

3.  Clinical implications of neuroimaging in stroke.

Authors:  Joffre E Olaya; Joseph R Keen; Frank P K Hsu
Journal:  Transl Stroke Res       Date:  2012-04-20       Impact factor: 6.829

Review 4.  Heterogeneity in the penumbra.

Authors:  Gregory J del Zoppo; Frank R Sharp; Wolf-Dieter Heiss; Gregory W Albers
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-06       Impact factor: 6.200

Review 5.  Application of proteomics to cerebrovascular disease.

Authors:  Mingming Ning; Mary Lopez; Jing Cao; Ferdinando S Buonanno; Eng H Lo
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

6.  Prognostic value of subacute crossed cerebellar diaschisis: single-photon emission CT study in patients with middle cerebral artery territory infarct.

Authors:  Masashi Takasawa; Manabu Watanabe; Shiro Yamamoto; Taku Hoshi; Tsutomu Sasaki; Kazuo Hashikawa; Masayasu Matsumoto; Naokazu Kinoshita
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

Review 7.  Advances in chronic cerebral circulation insufficiency.

Authors:  Da Zhou; Ran Meng; Si-Jie Li; Jing-Yuan Ya; Jia-Yue Ding; Shu-Ling Shang; Yu-Chuan Ding; Xun-Ming Ji
Journal:  CNS Neurosci Ther       Date:  2017-11-15       Impact factor: 5.243

Review 8.  Assessment of pathophysiology of stroke by positron emission tomography.

Authors:  W D Heiss; K Herholz
Journal:  Eur J Nucl Med       Date:  1994-05

9.  CT Density Changes with Rapid Onset Acute, Severe, Focal Cerebral Ischemia in Monkeys.

Authors:  Edwin M Nemoto; Oscar Mendez; Mary E Kerr; Andrew Firlik; Kevin Stevenson; Tudor Jovin; Howard Yonas
Journal:  Transl Stroke Res       Date:  2012-05-30       Impact factor: 6.829

Review 10.  Treatment of stroke in older patients. A state of the art review.

Authors:  G Harper
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.